(Q17143195)
Statements
674.1 dalton
1 reference
cyclic GMP-AMP (English)
19 October 2016
C₂₀H₂₄N₁₀O₁₃P₂
1 reference
cyclic GMP-AMP (English)
20 November 2016
C1C2C(C(C(O2)N3C=NC4=C3NC(=NC4=O)N)OP(=O)(OCC5C(C(C(O5)N6C=NC7=C6N=CN=C7N)O)OP(=O)(O1)O)O)O
1 reference
cyclic GMP-AMP (English)
20 November 2016
C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3NC(=NC4=O)N)OP(=O)(OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C6N=CN=C7N)O)OP(=O)(O1)O)O)O
1 reference
cyclic GMP-AMP (English)
20 November 2016
Identifiers
1 reference
cyclic GMP-AMP (English)
20 November 2016
2 references
cyclic GMP-AMP (English)
20 November 2016
2 references
2'-O,5'-O-((adenosine-3'-O,5'-O-diyl)bisphosphinico)guanosine (English)
20 November 2016
1 reference
2-Amino-9-[(1R,6R,8R,9R,10S,15R,17R,18R)-8-(6-amino-9H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxido-2,4,7,11,13,16-hexaoxa-3,12-diphosphatricyclo[13.2.1.0~6,10~]octadec-17-yl]-1,9-dihydro-6H-purin- (English)
20 November 2016
1 reference
cyclic GMP-AMP (English)
20 November 2016
1 reference
2'3'-cGAMP (English)
20 November 2016
1 reference
2'-O,5'-O-((adenosine-3'-O,5'-O-diyl)bisphosphinico)guanosine (English)
20 November 2016
1 reference
4O67 (English)
19 October 2016
1 reference
5CFQ (English)
19 October 2016
1 reference
4LEZ (English)
19 October 2016
1 reference
4LOH (English)
19 October 2016
1 reference
4LOJ (English)
19 October 2016
1 reference
4KSY (English)
19 October 2016